closing the gap between chemistry and biology: joining between text tombs and databases
DESCRIPTION
Progress in the biomedical sciences is critically dependent on explicit chemical structures and bioactivity results described in text. This applies across drug discovery, pharmacology, chemical biology, and metabolomics. However the entombing of the majority of these structures and associated data within patents, papers, abstracts and web pages has been a major barrier to progress. This presentation introduces the current public information flow from documents and its associated barriers, such as inadequate author specification of structures, journal pay walls precluding text mining and the patchiness of MeSH chemistry annotation for PubMed-to-PubChem connectivity. It then reviews trends that are lowering these barriers. These include the Google merge of over 50 million InChIKey(s) from PubChem, ChemSpider and UniChem, ChEMBL containing SAR for 0.8 million structures from 50K medicinal chemistry papers, over 20 million abstracts in PubMed, and full-text open patent chemistry in SureChemOpen bringing PubChem patent-extracted structures to 15 million. In addition, options such as Open Lab Books and figshare are expanding the choices for surfacing new structures. Methods will be outlined for establishing document-to-document and document-to-database links via chemical structures. These include the PubChem toolbox, protein targets in UniProt, PubChem BioAssay, ChEMBL indexing in UK PMC, SureChemOpen, chemicalize.org for text name-to-structure conversion , OSRA for image-to-structure conversion, Venny for set comparisons and InChIKey searching in Google [1]. Combined use of these approaches to make joins between patents, papers, abstracts chemical database entries, SAR data and drug target protein sequences will be illustrated with recent novel antimalarial lead compounds, patent-only BACE2 inhibitors and company code numbers in the NCATS repurposing list.TRANSCRIPT
[1]
Closing the gap between chemistry and biology: Joining between text tombs and
databases
Presentation for Uppsla University Department of Neuroscience, Sept 2013
By Christopher Southan
Curator for IUPHARdb, http://www.guidetopharmacology.org/
Queen's Medical Research Institute, University of Edinburgh
Email: [email protected]
Twitter: http://twitter.com/#!/cdsouthan
Blog: http://cdsouthan.blogspot.com/
LinkedIN: http://www.linkedin.com/in/cdsouthan
TW2Informatics: http://www.cdsouthan.info/Consult/CDS_cons.htm
Publications: http://www.citeulike.org/user/cdsouthan/order/year,,/publications
Presentations: http://www.slideshare.net/cdsouthan
[2]
Abstract
• Progress in the biomedical sciences is critically dependent on explicit chemical structures and bioactivity results described in text. This applies across drug discovery, pharmacology, chemical biology, and metabolomics. However the entombing of the majority of these structures and associated data within patents, papers, abstracts and web pages has been a major barrier to progress. This presentation introduces the current public information flow from documents and its associated barriers, such as inadequate author specification of structures, journal pay walls precluding text mining and the patchiness of MeSH chemistry annotation for PubMed-to-PubChem connectivity. It then reviews trends that are lowering these barriers. These include the Google merge of over 50 million InChIKey(s) from PubChem, ChemSpider and UniChem, ChEMBL containing SAR for 0.8 million structures from 50K medicinal chemistry papers, over 20 million abstracts in PubMed, and full-text open patent chemistry in SureChemOpen bringing PubChem patent-extracted structures to 15 million. In addition, options such as Open Lab Books and figshare are expanding the choices for surfacing new structures. Methods will be outlined for establishing document-to-document and document-to-database links via chemical structures. These include the PubChem toolbox, protein targets in UniProt, PubChem BioAssay, ChEMBL indexing in UK PMC, SureChemOpen, chemicalize.org for text name-to-structure conversion , OSRA for image-to-structure conversion, Venny for set comparisons and InChIKey searching in Google [1]. Combined use of these approaches to make joins between patents, papers, abstracts chemical database entries, SAR data and drug target protein sequences will be illustrated with recent novel antimalarial lead compounds, patent-only BACE2 inhibitors and company code numbers in the NCATS repurposing list.
[3]
The Chem < - > Bio Join
• Chemistry that does something: drug discovery, drug development, toxicology, pharmacology, systems chemical biology (probes), structural biology, metabolomics, chemical ecology, etc etc ….
• With the exception of some PubChem Bioassays, the majority of data is sill primarily archived in documents
[4]
Getting chemistry out of text is difficult
[5]
That’s why we used to have to pay
73 million
4,059,232
5.1 million
~ 20,000
[6]
The Chemical Representational Hextet: Different usage between documents and
databases
?
[7]
A recent NRDD article
• Just images and code numbers• No PubChem or ChemSpider IDs• No SMILES or InChIs• No molfiles for download• No links in or out• No MeSH > PubChem substances• Some cited sources might have IUPAC names
[8]
You can dig out structures from text for free:- but its hard work
[9]
What’s out there for free
• InChIKey in Google ~ 50 million • PubChem = 48 million • PubChem ROF + 250-800 Mw (lead-like) = 31 million• ChemSpider = 28 million • PubChem all docs (papers & patents) = 16 million • PubChem patents = 15 million• SureChemOpen = 14.5 million• PubChem journal sources (PubMed + ChEMBL) = 1 million
[10]
Medicinal chemistry patents (tombs with lids off)
• WO, C07D = 72,737 (assignee vs. year plots below)• ~ 50 novel structures with SAR per patent = ~ 3.5 million bioactives • Paradoxically now completely open for chemistry or any mining
[11]
PubMed: ~ 10% with chemistry (guarded tombs)
“Free full text” = 575,513 (24%)
[12]
Growth: (escaping the
tombs)• Patent “big bang”
(SureChem & SCRIPDB in 2012)
• Literature “slow burn” (ChEMBL 2009 jump)
• Paradox - patents:papers 15:1
(both sets of CIDs cumulative)
[13]
Databases <> structures < > documents:links, but few reciprocal
Abstracts
Patents
Papers
15 mill
0.2 mill (mainly MeSH)
0.8 mill (ChEMBL)
12K
[14]
Triaging document or webpage chemistry
• Identify the structure specification types, e.g.– Semantic names (all sources)– Code names (press releases, papers and abstracts) – IUPAC names (papers, patents and abstracts)– Images (papers, patents, & Google images)– SMILES (open lab books)– InChi strings (open lab books)– SDF files (open lab books, & github)
Convert these to a structure (e.g. SDF, SMILES, InChI) then:– Search InChIKey in Google– Search major databases– Search SureChemOpen– Compare extracted sets for intersects and diffs – Extend exact match connectivity with similarity searching
[15]
Triage example: a new antimalaria
The MMV390048 code name is linked to an image in press reports but is PubChem and PubMed -ve
[16]
Images: convert and search
Real chemists sketch them in a jiffy;
the rest of us can use OSRA: Optical Structure Recognition Application
(after editing, CS(=O)(=O)c3ccc(C2=CN=C(N)C(C1=CCC(C(F)(F)F)N=C1)C2)cc3)
[17]
Making connections: image > strucure > database > documents
CID 53311393 > ChEMBL > PubMedSureChem or chemicalize.org > patent
[18]
Patent SAR from WO2011086531:Collating activities via SureChemOpen
CID 53311393 >
[19]
Patent SAR results: top-20 from 39 IC50s
[20]
Results > figshare
http://figshare.com/articles/Patent_SAR_for_MMV390048/657979
[21]
Structures > MyNCBI
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1zWhcobieZbIouGfUdsdbHek5/.
[22]
SAR Table: iOS app from Molecular
Materials Informatics
SureChemOpen strucs ->
manual data collation ->
PubChem CIDs -> SDF ->
Dropbox -> SAR Table
-> edit in data, R-group decompose
-> share
[23]
InChIKey in Google: instant orthogonal joining
[24]
Chemicalize.org: 413 strucs from WO2011086531
CID 53311393 ->
[25]
Using OPSIN and chemcalize.org to fix recalcitrant IUPACs from WO2011086532
Can quasi-manually extract ~ 10 more “split IUPAC” examples
[26]
Clustering document extraction sets: CheS-Mapper
WO2011086531 -> chemicalize.org -> 413 cpds download -> CheS-Mapper -> cluster 8 -> export 53 cpds
[27]
PubChem -> ChEMBL -> PMID -> assay -> strucs
• CHEMBL2041980 (structure)• PMID 22390538 (paper)• CHEMBL2045642 (assay for 32 strucs
from paper)• The 32 CIDs all have patent matches
[28]
Venny: intersects, diffs, de-dupes and merges
1) WO2011086531 matches in PubCHem
2) CheS-Mapper cluster 8 from WO2011086532
3) ChEMBL assayed cpds from PMID 22390538
(handles any regular strings e.g. db IDs, SMILES, IChI or InChIKey)
[29]
[30]
NCATS/MRC: the joy of codes with no structures
http://cdsouthan.blogspot.se/2012/09/mrc-22-vs-ncats-58-repurposing-lists.html
[31]
Code name-to-structure mapping:
Dig out the code names
PubChem Substance
PubChem Compound
PubMed/MeSH
Google Scholar
Google Images
Google open (filtered)
[32]
Sometimes the system works
[33]
PubMed > ChEMBL
[34]
Sometimes you get missing and cryptic links
[35]
NVP-Bxd552: Google results
[36]
BACE2: Almost no chemistry in papers
[37]
BACE2
1. WO2013054291 > chemicalize.org 2. Download 450 structures3. Upload to PubChem search
[38]
Scibite > Alerts for new chemistry
[39]
Conclusions
• The ability to extract chemical structures from text and web sources has been transformed by an expansion of the public toolbox
• The PubChem big-bang increases probability of extraction having database exact or similarity matches
• Paradoxically, the patent corpus is now completely open while access to journal text is still restricted
• However, ChEMBL has extracted ~ 0.8 mill. SAR-linked and target mapped structures from ~ 50K papers
• The submission of ~15 mill. patent structures to PubChem ensures at least representation from the majority of medicinal chemistry patents (many of which spawned the subsequent ChEMBL papers)
• Those who want to share their structures globally (e.g. OSDD) have an expanding set of options for surfacing their results.
[40]
References